Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

CD8 T cells recruited early in mouse polyomavirus infection undergo exhaustion.

Wilson JJ, Pack CD, Lin E, Frost EL, Albrecht JA, Hadley A, Hofstetter AR, Tevethia SS, Schell TD, Lukacher AE.

J Immunol. 2012 May 1;188(9):4340-8. doi: 10.4049/jimmunol.1103727. Epub 2012 Mar 23.

2.

CD8+ T cells targeting a single immunodominant epitope are sufficient for elimination of established SV40 T antigen-induced brain tumors.

Tatum AM, Mylin LM, Bender SJ, Fischer MA, Vigliotti BA, Tevethia MJ, Tevethia SS, Schell TD.

J Immunol. 2008 Sep 15;181(6):4406-17.

3.

TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activation.

de Witte MA, Bendle GM, van den Boom MD, Coccoris M, Schell TD, Tevethia SS, van Tinteren H, Mesman EM, Song JY, Schumacher TN.

J Immunol. 2008 Aug 15;181(4):2563-71.

4.

An SV40 VP1-derived epitope recognized by CD8+ T cells is naturally processed and presented by HLA-A*0201 and cross-reactive with human polyomavirus determinants.

Tagaram HR, Watson AM, Lemonnier FA, Staveley-O'Carroll K, Tevethia SS, Schell TD.

Virology. 2008 Jun 20;376(1):183-90. doi: 10.1016/j.virol.2008.02.033. Epub 2008 Apr 10.

5.
7.

Diversity of escape variant mutations in Simian virus 40 large tumor antigen (SV40 Tag) epitopes selected by cytotoxic T lymphocyte (CTL) clones.

Mylin LM, Schell TD, Epler M, Kusuma C, Assis D, Matsko C, Smith A, Allebach A, Tevethia SS.

Virology. 2007 Jul 20;364(1):155-68. Epub 2007 Mar 21.

9.

Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.

Otahal P, Hutchinson SC, Mylin LM, Tevethia MJ, Tevethia SS, Schell TD.

J Immunol. 2005 Jul 15;175(2):700-12.

10.

Immune defects in 28-kDa proteasome activator gamma-deficient mice.

Barton LF, Runnels HA, Schell TD, Cho Y, Gibbons R, Tevethia SS, Deepe GS Jr, Monaco JJ.

J Immunol. 2004 Mar 15;172(6):3948-54.

11.

Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Va14Ja18 natural T(iNKT) cell receptor [corrected].

Stanic AK, Shashidharamurthy R, Bezbradica JS, Matsuki N, Yoshimura Y, Miyake S, Choi EY, Schell TD, Van Kaer L, Tevethia SS, Roopenian DC, Yamamura T, Joyce S.

J Immunol. 2003 Nov 1;171(9):4539-51. Erratum in: J Immunol. 2004 Jan 1;172(1):717.

12.

In vivo ligation of CD40 enhances priming against the endogenous tumor antigen and promotes CD8+ T cell effector function in SV40 T antigen transgenic mice.

Staveley-O'Carroll K, Schell TD, Jimenez M, Mylin LM, Tevethia MJ, Schoenberger SP, Tevethia SS.

J Immunol. 2003 Jul 15;171(2):697-707.

13.

New associations of human papillomavirus, Simian virus 40, and Epstein-Barr virus with human cancer.

Wong M, Pagano JS, Schiller JT, Tevethia SS, Raab-Traub N, Gruber J.

J Natl Cancer Inst. 2002 Dec 18;94(24):1832-6. Review. No abstract available.

PMID:
12488476
14.
16.
17.

Cytotoxic T lymphocytes in SV40 infections.

Schell TD, Tevethia SS.

Methods Mol Biol. 2001;165:243-56. No abstract available.

PMID:
11217391
18.
21.

Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice.

Schell TD, Mylin LM, Georgoff I, Teresky AK, Levine AJ, Tevethia SS.

J Virol. 1999 Jul;73(7):5981-93.

22.

Immunogenicity of herpes simplex virus type 1 mutants containing deletions in one or more alpha-genes: ICP4, ICP27, ICP22, and ICP0.

Brehm M, Samaniego LA, Bonneau RH, DeLuca NA, Tevethia SS.

Virology. 1999 Apr 10;256(2):258-69.

23.
24.

A molecular basis for how a single TCR interfaces multiple ligands.

Boesteanu A, Brehm M, Mylin LM, Christianson GJ, Tevethia SS, Roopenian DC, Joyce S.

J Immunol. 1998 Nov 1;161(9):4719-27.

25.

Cytotoxic T lymphocyte recognition sequences as markers for distinguishing among tumour antigens encoded by SV40, BKV and JCV.

Tevethia SS, Mylin L, Newmaster R, Epler M, Lednicky JA, Butel JS, Tevethia MJ.

Dev Biol Stand. 1998;94:329-39.

PMID:
9776254
26.

Role of a subdominant H-2Kd-restricted SV40 tumor antigen cytotoxic T lymphocyte epitope in tumor rejection.

Newmaster RS, Mylin LM, Fu TM, Tevethia SS.

Virology. 1998 May 10;244(2):427-41.

27.
29.

Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.

Fu TM, Bonneau RH, Epler M, Tevethia MJ, Alam S, Verner K, Tevethia SS.

Virology. 1996 Aug 1;222(1):269-74.

30.

Hierarchy among multiple H-2b-restricted cytotoxic T-lymphocyte epitopes within simian virus 40 T antigen.

Mylin LM, Bonneau RH, Lippolis JD, Tevethia SS.

J Virol. 1995 Nov;69(11):6665-77.

34.

Simian virus 40 T antigen as a carrier for the expression of cytotoxic T-lymphocyte recognition epitopes.

Fu TM, Bonneau RH, Tevethia MJ, Tevethia SS.

J Virol. 1993 Nov;67(11):6866-71.

35.

Epitope specificity of H-2Kb-restricted, HSV-1-, and HSV-2-cross-reactive cytotoxic T lymphocyte clones.

Bonneau RH, Salvucci LA, Johnson DC, Tevethia SS.

Virology. 1993 Jul;195(1):62-70.

PMID:
7686314
36.

Antibody response to human papovavirus JC (JCV) and simian virus 40 (SV40) T antigens in SV40 T antigen-transgenic mice.

Tevethia SS, Epler M, Georgoff I, Teresky A, Marlow M, Levine AJ.

Virology. 1992 Sep;190(1):459-64.

PMID:
1382342
40.

Localization of common cytotoxic T lymphocyte recognition epitopes on simian papovavirus SV40 and human papovavirus JC virus T antigens.

Deckhut AM, Tevethia MJ, Haggerty S, Frisque RJ, Tevethia SS.

Virology. 1991 Jul;183(1):122-32.

PMID:
1711255
41.

Dissection of H-2Db-restricted cytotoxic T-lymphocyte epitopes on simian virus 40 T antigen by the use of synthetic peptides and H-2Dbm mutants.

Tevethia SS, Lewis M, Tanaka Y, Milici J, Knowles B, Maloy WL, Anderson R.

J Virol. 1990 Mar;64(3):1192-200.

42.

Recognition of simian virus 40 T antigen by cytotoxic T lymphocytes.

Tevethia SS.

Mol Biol Med. 1990 Feb;7(1):83-96. Review.

PMID:
2157938
44.
45.

Frequency analysis of simian virus 40-specific cytotoxic T lymphocyte precursors in the high responder C57BL/6 mouse strain.

Jennings SR, Fresa KL, Lippe PA, Milici JE, Tevethia SS.

J Gen Virol. 1988 Oct;69 ( Pt 10):2493-503.

PMID:
2459302
47.
48.

Clustering of antigenic sites recognized by cytotoxic T lymphocyte clones in the amino terminal half of SV40 T antigen.

Tanaka Y, Tevethia MJ, Kalderon D, Smith AE, Tevethia SS.

Virology. 1988 Feb;162(2):427-36.

PMID:
2448953

Supplemental Content

Loading ...
Support Center